Panda Santosh K, Panda Subhra Snigdha, Pradhan Deepti D, Nayak Manas K, Ghosh Arpan, Mohakud Nirmal K
Neonatology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Microbiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Cureus. 2022 Apr 5;14(4):e23859. doi: 10.7759/cureus.23859. eCollection 2022 Apr.
Introduction Data are scarce on the hematological and biochemical changes caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in neonates. This study aimed to compare hematological and biochemical parameters in SARS-CoV-2-positive neonates with healthy neonates born to mothers diagnosed with coronavirus disease 2019 (COVID-19) and assess disease severity in both groups. Methodology This prospective observational study was conducted at a COVID-19 hospital at Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India, from May 1 to November 30, 2020. Forty-eight babies, including 39 inborn and nine outborn, were enrolled in the study after their parents provided written informed consent. Neonates were diagnosed with COVID-19 via nasopharyngeal real-time reverse transcription-polymerase chain reaction testing. The hematological and biochemical parameters of these 48 neonates were recorded and analyzed. Results SARS-CoV-2-infected neonates had lower hemoglobin, neutrophil to lymphocyte ratio, total white blood cell count, and absolute neutrophil count compared to noninfected babies (p<0.05). All SARS-CoV-2-infected neonates had serum transaminase levels and renal function tests within reference ranges. We saw no significant differences in hematological and biochemical parameters among asymptomatic SARS-CoV-2-infected and noninfected neonates. Conclusions Hematological and biochemical parameters between asymptomatic SARS-CoV-2-infected and non-infected neonates were similar. The blood count abnormalities found in SARS-CoV-2-infected neonates could be due to other associated neonatal comorbidities. According to our results, asymptomatic SARS-CoV-2-infected newborns need close monitoring rather than a battery of investigation.
引言 关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对新生儿造成的血液学和生化变化的数据很少。本研究旨在比较感染SARS-CoV-2的新生儿与母亲被诊断为2019冠状病毒病(COVID-19)的健康新生儿的血液学和生化参数,并评估两组的疾病严重程度。方法 本前瞻性观察性研究于2020年5月1日至11月30日在印度奥里萨邦布巴内斯瓦尔市卡林加医学科学研究所的一家COVID-19医院进行。在获得父母的书面知情同意后,48名婴儿(包括39名足月儿和9名早产儿)被纳入研究。通过鼻咽实时逆转录聚合酶链反应检测诊断新生儿是否感染COVID-19。记录并分析了这48名新生儿的血液学和生化参数。结果 与未感染的婴儿相比,感染SARS-CoV-2的新生儿血红蛋白、中性粒细胞与淋巴细胞比值、白细胞总数和绝对中性粒细胞计数较低(p<0.05)。所有感染SARS-CoV-2的新生儿血清转氨酶水平和肾功能检查均在参考范围内。我们发现无症状感染SARS-CoV-2的新生儿与未感染的新生儿在血液学和生化参数上没有显著差异。结论 无症状感染SARS-CoV-2的新生儿与未感染的新生儿在血液学和生化参数上相似。感染SARS-CoV-2的新生儿出现的血细胞计数异常可能是由于其他相关的新生儿合并症。根据我们 的结果,无症状感染SARS-CoV-2的新生儿需要密切监测,而不是进行一系列检查。